2 Syrup Exported By Maiden Before Product Permission

Hisar : An investigation into the death of 66 children in the Gambia from the cough syrup of Kundli-based Maiden Pharmaceutical Ltd in Sonepat district has revealed that the company had exported 4 types of medicine to Gambia, two of which were even before permission was granted to manufacture the formulation.

Not only this, a lot of flaws have also been found in making BMR (Batch Manufacturing Record) and many other irregularities have also been found.

Maiden Pharmaceutical Ltd was inspected by a team of Central Drugs Standard Control Organization (CDSCO) drug inspectors Sandeep Kumar, Devendra Pratap Singh and Panipat SDCO Rakesh Dahiya after the matter came to light. These defects were found during inspection.

According to the report, Kofexmalin Baby Cough Syrup and MaGrip n Cold Syrup were exported earlier, while permission to manufacture the same was taken later.

In this case, Panipat’s advocate Yashpal had sent a complaint to PM Modi, accusing Haryana FDA’s state drug controller Manmohan Taneja of changing cough syrup samples by taking a bribe of Rs 5 crore from the owner of the company.

The PMO has forwarded it to the Chief Secretary, Government of Haryana for appropriate action.

FDA’s Deputy State Drug Controller Lalit Kumar Goel called the complainant for investigation, but the complainant did not join the investigation, saying it was futile to conduct an investigation by a junior officer against a senior officer.

Contacted Manmohan Taneja in the matter and sent a text message, but he did not present his stand.

  • Related Posts

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Minister directs quality testing, optimum utilisation of medical infra Kathua: Minister for Health and Medical Education and Social Welfare, Sakeena Itoo, Monday visited the Modern Drug Testing Laboratory and Government…

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes